B

Bangkok Lab and Cosmetic PCL
SET:BLC

Watchlist Manager
Bangkok Lab and Cosmetic PCL
SET:BLC
Watchlist
Price: 5 THB -2.91% Market Closed
Market Cap: 3B THB
Have any thoughts about
Bangkok Lab and Cosmetic PCL?
Write Note

Gross Margin
Bangkok Lab and Cosmetic PCL

30.7%
Current
31%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.7%
=
Gross Profit
470m
/
Revenue
1.5B

Gross Margin Across Competitors

Country TH
Market Cap 3B THB
Gross Margin
31%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 744.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.9B USD
Gross Margin
69%
Country US
Market Cap 258.4B USD
Gross Margin
77%
Country CH
Market Cap 200.6B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 180.7B CHF
Gross Margin
75%
Country US
Market Cap 146.9B USD
Gross Margin
71%
No Stocks Found

Bangkok Lab and Cosmetic PCL
Glance View

Market Cap
3B THB
Industry
Pharmaceuticals

Bangkok Lab & Cosmetic PCL engaes in the provision of pharmaceuticals and health products. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2023-06-21. The firm is engaged in the production of medicines and health products by selecting raw materials. The firm has produced more than 100 products. Its products include ZENZERA 200 SUSPENSION, ZENZERA, SYNOVAR UC40, RADIARA, PROCEMINE, FANGO-B, EMBLICOF COUGH MIXTURE, CLINIGEL STERILE, RAQUA FIBROTA, RAQUA COLLAGEN, SYNOVAR UC, SYNOVAR POWDER, NACOXIB, LUTI-BERRY MIXED, ZIGA GEL (orange), ZERTINE SYRUP, VIZO Cream, SPORAXYL CREAM, NORAPHEN, MURHINOL-250 SYRUP, NORFLOXYL 400, NOCID, MURHINOL-250 SYRUP, MUCOBROX, GYNOSTEN CREAM, and GYNOSTEN 500, AROTIKA COOL GEL, ALLERAX-FC, AROTIKA RUB LOTION (SPRAY), Calza c Dietary Supplement, Calza PLUS POWDER Dietary, and Calza-750 TAB FC, among others. Its products are distributed through Bangkok Drug Co., Ltd., Beereach (Thailand) Co., Ltd., Pharmaline Company Limited, Pharma Alliance Company Ltd., and Bangkok Medica Co., Ltd.

BLC Intrinsic Value
3.88 THB
Overvaluation 22%
Intrinsic Value
Price
B

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.7%
=
Gross Profit
470m
/
Revenue
1.5B
What is the Gross Margin of Bangkok Lab and Cosmetic PCL?

Based on Bangkok Lab and Cosmetic PCL's most recent financial statements, the company has Gross Margin of 30.7%.